Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Erlotinib Hydrochloride × Lymphoid × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 18 Gastrointestinal 10 Head & Neck 6 Tumor-Agnostic 4 Dermatologic 3 Genitourinary 2 Breast 2 Sarcoma 1 Plasma cell 1 Lymphoid 1 CNS 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Cyclophosphamide 322 Rituximab 293 Vincristine 149 venetoclax 145 fludarabine 144 Doxorubicin 144 Prednisone 138 Specimen Handling 116 obinutuzumab 103 Lenalidomide 102 Biopsy 97 Magnetic Resonance Spectroscopy 95 ibrutinib 92 Cytarabine 91 Dexamethasone 87 Etoposide 85 fludarabine phosphate 84 Methotrexate 84 zanubrutinib 74 acalabrutinib 72 Bendamustine Hydrochloride 71 CT-P10 59 blinatumomab 57 pembrolizumab 54 Gemcitabine 46 prednylidene 41 Nivolumab 41 Mercaptopurine 41 deltacortene 40 Whole-Body Irradiation 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297606 2026-03-04

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡